Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Anthrax 2014 NIGMS 5R01GM035370-29 Genetics of secretion in yeast NOVICK, PETER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $416,251
Anthrax 2014 NIAID 5R01AI057472-10 Isolation of new phage enzymes to kill B. anthracis FISCHETTI, VINCENT ROCKEFELLER UNIVERSITY NY $418,275
Anthrax 2014 NIAID 5R01AI069227-08 Surface Proteins of Bacillus anthracis SCHNEEWIND, OLAF UNIVERSITY OF CHICAGO IL $384,624
Anthrax 2014 NIAID 5R01AI077703-06 Physical Principles of Bacterial Toxin Translocation across Membranes KRANTZ, BRYAN UNIVERSITY OF CALIFORNIA BERKELEY CA $372,949
Anthrax 2014 NIAID 5F31AI094961-04 Protective Effects of Anti-BclA Antibodies in Bacillus anthracis Infection RODRIGUEZ BARRANTES, JUAN UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $34,538
Anthrax 2014 NIAID 5R01AI105172-02 Conjugate Anthrax Vaccine with Dual Virulence Factor Specificity GIRI, LALLAN BIOLOGICS RESOURCES, LLC MD $1,153,802
Anthrax 2014 NIAID 1R21AI109111-01 Stabilization and regulation of a Bacillus anthracis spore lytic enzyme POPHAM, DAVID VIRGINIA POLYTECHNIC INST AND ST UNIV VA $223,618
Anthrax 2014 NHLBI 1R01HL118390-01A1 Membrane Serine Protease Activities in Protease Activated Receptor Signaling ANTALIS, TONI UNIVERSITY OF MARYLAND BALTIMORE MD $383,750
Anthrax 2014 NIGMS 5R01GM097357-03 Integrated Methods for Structural Elucidation of Proteins and Macromolecular Comp WILLIAMS, EVAN UNIVERSITY OF CALIFORNIA BERKELEY CA $250,008
Anthrax 2014 NIAID 5R01AI104586-03 IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors JOHNSON, ALAN HAWAII BIOTECH, INC. HI $1,528,431
Anthrax 2014 NIGMS 5SC1GM095475-04 Receptor disulfide allosteric regulation of anthrax toxin action SUN, JIANJUN UNIVERSITY OF TEXAS EL PASO TX $224,250
Anthrax 2014 NIAID 5R01AI099097-02 Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity HUGHES, MOLLY UNIVERSITY OF VIRGINIA VA $395,000
Anthrax 2014 NIAID 5R01AI093365-04 Immunoassay for capsular antigen for rapid diagnosis of anthrax KOZEL, THOMAS UNIVERSITY OF NEVADA RENO NV $893,748
Anthrax 2014 NIAID 1F30AI110036-01 Assembly of the envelope of Bacillus anthracis vegetative forms LUNDERBERG, JUSTIN UNIVERSITY OF CHICAGO IL $44,914
Anthrax 2014 NIAID 5R21AI099851-02 Microparticle Capture-Based Analysis of Lymph Node Proteome POPOV, SERGUEI GEORGE MASON UNIVERSITY VA $220,875
Anthrax 2014 NIAID 1F31AI110101-01 Functional similarity of PRD-containing virulence regulators in B. anthracis RAYNOR, MALIK UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $29,006
Anthrax 2014 NIAID 5R01AI098884-03 Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive SIM, B. PROTEIN POTENTIAL, LLC MD $1,100,257
Anthrax 2014 NIAID 5R01AI093459-04 IMPDH-targeted antibiotics for select agents HEDSTROM, LIZBETH BRANDEIS UNIVERSITY MA $1,058,736
Anthrax 2014 NIAID 1U19AI109713-01 8682 Broad spectrum Tricyclics GyrB, ParE inhibitors for antibacterial applications BARTIZAL, KENNETH TRIUS THERAPEUTICS, INC. CA $731,729
Anthrax 2014 NIAID 5R01AI097167-03 Iron Acquisition in Anthrax MARESSO, ANTHONY BAYLOR COLLEGE OF MEDICINE TX $391,250
Anthrax 2014 NIGMS 5SC3GM084809-06 Synthesis of new classes of metal ion chelators for therapeutic applications GOPALAN, ARAVAMUDAN NEW MEXICO STATE UNIVERSITY LAS CRUCES NM $109,500
Anthrax 2014 NIAID 5R01AI090802-05 Optimization of Neoglycoside Antibiotics for Nosocomial Pathogens and Select Agen DRUSANO, GEORGE UNIVERSITY OF FLORIDA FL $724,489
Anthrax 2014 NIAID 1R01AI110713-01 Analyzing a novel mechanism of action of bacterial cAMP producing toxins BIER, ETHAN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $537,892
Anthrax 2014 NIAID 5R01AI033537-20 Virulence Gene Expression by Bacillus anthracis KOEHLER, THERESA UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $295,502
Anthrax 2014 NIAID 5R01AI090685-05 Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis BUNCE, RICHARD OKLAHOMA STATE UNIVERSITY STILLWATER OK $491,851
Anthrax 2014 NIAID 1R15AI099897-01A1 OBSTRUCTING TOXIN'S PATHWAYS: UNIVERSAL INHIBITORS OF BINARY BACTERIAL TOXINS NESTOROVICH, EKATERINA CATHOLIC UNIVERSITY OF AMERICA DC $423,155
Anthrax 2014 NIAID 5R44AI090719-05 Development of a Novel PolC Inhibitor as a Gram-Positive Antibiotic JARVIS, THALE CRESTONE, INC. CO $1,000,000
Anthrax 2014 NIAID 1R01AI111466-01 Enhanced Shelf-life Nanovaccine Formulation for Immunity to Biodefense Pathogens NARASIMHAN, BALAJI IOWA STATE UNIVERSITY IA $349,999
Anthrax 2014 NIAID 1R01AI111538-01 Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart RAO, VENIGALLA CATHOLIC UNIVERSITY OF AMERICA DC $693,061
Anthrax 2014 NIAID 1R01AI111535-01 Detection of Biodefense Pathogens Using Phage Diagnostics SCHOFIELD, DAVID GUILD ASSOCIATES, INC. OH $537,529
Anthrax 2014 NIAID 1R01AI111495-01 Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho PORTER, MARC UNIVERSITY OF UTAH UT $918,238
Anthrax 2014 NIAID 5R01AI093493-04 A novel anti-spore nasal vaccine for protection from anthrax DRIKS, ADAM LOYOLA UNIVERSITY CHICAGO IL $663,922
Anthrax 2014 NIAID 5R01AI095293-03 Bacillus Anthracis and Complement XU, YI TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $356,712
Anthrax 2014 NIAID 5R01AI095488-03 Peptide-Based Quorum Sensing Controlling Virulence in Bacillus anthracis LEE, HYUNWOO UNIVERSITY OF ILLINOIS AT CHICAGO IL $398,750
Anthrax 2014 NIAID 5R01AI093370-05 Novel multivalent vaccine for anthrax and botulinum MOHAMADZADEH, MANSOUR UNIVERSITY OF FLORIDA FL $578,055
Anthrax 2014 NIAID 2U19AI062629-11 7600 Toxin-Mediated Suppression of Human PBMC Responses During Bacteremia BALLARD, JIMMY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $484,781
Anthrax 2014 NIAID 2U19AI062629-11 7601 Mechanisms by which B. anthracis Spores Escape the Lung METCALF, JORDAN UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $461,316
Anthrax 2014 NIAID 2U19AI062629-11 7602 Anti-Peptidoglycan Antibodies and Complement in Anthrax Pathogenesis COGGESHALL, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $372,221
Anthrax 2014 NIAID 2U19AI062629-11 7603 Humoral Mechanisms of Protection from Bacillus anthracis Sepsis FARRIS, A. DARISE OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $475,872
Anthrax 2014 NIAID 2U19AI062629-11 7604 Administrative Core COGGESHALL, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $163,777
Anthrax 2014 NIAID 2U19AI062629-11 7605 Pilot Project Program BALLARD, JIMMY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $148,889
Anthrax 2014 NIAID 2U19AI062629-11 7606 Animal Model Core LUPU, FLOREA OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $506,221
Anthrax 2014 NIAID 2U19AI062629-11 7607 Flow Cytometry Core THOMPSON, LINDA OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $74,444
Anthrax 2014 NIAID 2U19AI062629-11 7608 Human Antibody Core SMITH, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $223,333
Anthrax 2014 OD 1S10OD018530-01 Orbitrap Fusion Tribrid Mass Spectrometer AZADI, PARASTOO UNIVERSITY OF GEORGIA GA $750,000
Anthrax 2014 NEI 1R21EY024734-01 Phage Display Selection of Antiangiogenic CMG2 Cyclic Peptide Antagonists CHRISTENSEN, KENNETH CLEMSON UNIVERSITY SC $214,590
Anthrax 2014 NIAID 1R41AI106153-01A1 A molecularly targeted pre- and post-exposure vaccine for anthrax OSCHERWITZ, JON VLP BIOTECH, INC. CA $260,205
Anthrax 2014 NIAID 1R43AI114222-01 A Cell-Penetrating Anthrax Antitoxin BELLE, ARCHANA PLANET BIOTECHNOLOGY, INC. CA $219,367
Anthrax 2014 NIAID 272201000035C-9-0-1 Development of Technologies to Facilitate the Use of and Response to Vaccines LEMIALE, LAURENCE EMERGENT PRODUCT DEVELOPMENT GAITHERSBUR $10,928,292
Anthrax 2014 NCI 261200800001E-66-0-3 DCTD Computer Support HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. $2,767,982
Anthrax 2014 NIAID 272201200003I-1-27200004-1 Task X 4: Assessment of Simple Adjuvants to Enhance Anthrax Vaccines SABOURIN, CAROL BATTELLE CENTERS/PUB HLTH RES & EVALUATN $196,323
Anthrax 2014 NIAID 272201000003I-3-27200002-1 Task B01: Validation of the MSD Protective Antigen(PA)-ECL Assay BRUCE, MARY BATTELLE CENTERS/PUB HLTH RES & EVALUATN $37,068
Anthrax 2014 NIAID 272201000027C-7-0-8 Microbiology and Infectious Diseases Biological Research Resource Repository STEDMAN, TIMOTHY AMERICAN TYPE CULTURE COLLECTION $458,773
Anthrax 2014 NIAID 272201100028C-11-0-3 DEVELOPMENT OF NOVEL TETRACYCLINE COUNTERMEASURES FOR RESPIRATORY DISEASES RADCLIFF, ANNE CUBRC, INC. NY $3,023,963
Anthrax 2014 NIAID N01AI30062-30-0-1 In Vitro and Animal Models for Emerging Diseases and Biodefense NO PI IDENTIFIED PUBLIC HEALTH ENGLAND UK $73,054
Anthrax 2014 NIAID 272201200026C-5-0-2 STRUCTURAL GENOMICS CENTERS FOR INFECTIOUS DISEASES ANDERSON, WAYNE NORTHWESTERN UNIVERSITY AT CHICAGO $1,493,610
Anthrax 2014 NIAID 272201300029C-2-0-1 Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV) KOONTZ, CASEY NIH $3,529,059
Anthrax 2014 NIAID 4R33AI102223-03 Host Vascular Mechanism for Therapeutic Protection against Select Pathogens CHAN, JOANNE HAMPTON UNIVERSITY VA $444,000
Anthrax 2014 NIAID 272201100022I-4-27200004-2 Task 4: The Interventional Agent Development Services program MIRSALIS, JON SRI INTERNATIONAL $354,618
Anthrax 2014 NIAID 272201200034C-4-0-1 Technologies to Advance Next Generation Anthrax Vaccines YUSIBOV, VIDADI CENTER FOR EXPERMENTAL SOFTWARE ENGR MD MD $991,091
Anthrax 2014 NIAID 272201000036C-6-0-1 Development of Technologies to Facilitate the use and Response of Vaccines GURWITH, MARC PAXVAX, INC. $651,370
Anthrax 2014 NIAID 272201000003I-4-27200003-1 Task C01: Efficacy Testing of Therapeutics Against Inhalational Anthrax in NHPs BRUCE, MARY BATTELLE CENTERS/PUB HLTH RES & EVALUATN OH $73,557
Anthrax 2014 NIAID 272201400038C-0-0-1 DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N LEMIALE, LAURENCE EMERGENT PRODUCT DEVELOPMENT GAITHERSBUR MD $7,386,039
Anthrax 2014 NIAID 272201100012I-0-27200004-1 Task A11: In vitro assessments for antimicrobial activity against Bio-defense pathogens RAYNER, JONATHAN SOUTHERN RESEARCH INSTITUTE AL $96,080
Anthrax 2014 NIAID 272201400040C-0-0-1 DEVELOPMENT OF ANTHRAX VACCINE FORMULATIONS TROYER, JOHN PHARMATHENE, INC. MD $5,206,725
Anthrax 2014 NCI 1ZIABC009369-24 Studies of Receptor Interactions and Effects of Alarmins OPPENHEIM, JOOST NIH $991,767
Anthrax 2014 NIDDK 1ZIADK059701-41 Reactions And Immunochemistry Of Carbohydrates KOVAC, PAVOL NIH $754,795
Anthrax 2014 NIAID 1ZIAAI000929-12 Vaccines and Therapeutics for Anthrax LEPPLA, STEPHEN NIH $795,740
Anthrax 2014 NIAID 1ZIAAI000936-11 Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases LANE, CLIFFORD NIH $175,611
Anthrax 2014 NIAID 1ZIAAI000984-08 Influenza and Emerging Infectious Diseases DAVEY, RICHARD NIH $2,058,761
Anthrax 2014 NIAID 1ZIAAI001030-07 Molecular Genetics and Pathogenesis of Anthrax LEPPLA, STEPHEN NIH $454,709
Anthrax 2014 NIAID 1ZIAAI001031-07 Structure and Function of Virulence Factors of Bacillus anthracis LEPPLA, STEPHEN NIH $568,386
Anthrax 2014 NIAID 1ZIAAI001032-07 Pathophysiological Actions of Anthrax Virulence Determinants LEPPLA, STEPHEN NIH $454,709


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer